Publications by authors named "Waseem F Al Tameemi"
Article Synopsis
- Beta-thalassemia major (β-TM) is a genetic disorder that leads to severe anemia and requires lifelong blood transfusions, often causing serious health issues. The THALEMPA study explored how empagliflozin (EMPA) affects patients with β-TM who also have type 2 diabetes mellitus (T2DM), focusing on disease severity and complications.
- The study involved 20 patients who were divided into an EMPA group, which received 10 mg of the drug, and a control group with standard care, monitoring various health parameters over three months.
- Results showed that EMPA significantly improved hemoglobin levels and reduced liver enzyme levels, serum ferritin, and uric acid levels, indicating potential
